In addition, TMSB10 is elevated in renal cell carcinoma (RCC) and modulates malignant cell metastasis by stimulating epithelial‐mesenchymal transition, which induces TMSB10 as a candidate therapeutic biomarker for RCC.13 Here, TMSB10 is linked to renal cell carcinoma.